Organon & Co
711 hedge funds and large institutions have $2.94B invested in Organon & Co in 2023 Q4 according to their latest regulatory filings, with 131 funds opening new positions, 188 increasing their positions, 279 reducing their positions, and 135 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
711
Holders Change
-13
Holders Change %
-1.8%
% of All Funds
10.42%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.01%
New
131
Increased
188
Reduced
279
Closed
135
Calls
$39.8M
Puts
$44.6M
Net Calls
-$4.84M
Net Calls Change
+$12.7M
Top Buyers
| 1 |
BlackRock
New York
|
+$257M |
| 2 |
Morgan Stanley
New York
|
+$125M |
| 3 |
SPC
Slate Path Capital
New York
|
+$51.6M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$45.9M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$42.5M |
Top Sellers
| 1 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
-$223M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$123M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$87.3M |
| 4 |
State Street
Boston,
Massachusetts
|
-$61.7M |
| 5 |
Amundi
Paris,
France
|
-$38.2M |
